Facebook post by University of Helsinki

The increased risk of Alzheimer's is especially associated with hormone therapy exposure of over 10 years. The results are surprising: – In our previous studies we have demonstrated that postmenopausal hormone therapy decreases the risk of cardiovascular diseases, and also potentially the risk of vascular dementia. The mechanisms of Alzheimer’s disease differ, however, from those of vascular diseases, says researcher Tomi Mikkola.
Postmenopausal hormone therapy might increase the risk of Alzheimer’s disease | University of Helsinki helsinki.fi

A newly published Finnish study compares the postmenopausal hormone therapy use of women diagnosed with Alzheimer’s and their healthy controls.